Indian Pharma sector seeks six months LC extension from RBI Usha Sharma Apr 6, 2020 Pharmexcil has requested the RBI to consider giving an extension of six months for due payments against non fund limits through…
Engaging with authorities to address challenges regarding manufacturing, distribution of drugs: OPPI Press Trust of India Apr 6, 2020 OPPI continues to remain engaged with the relevant authorities to ensure that these challenges are overcome at the earliest, he…
Fortifying defence against zoonoses Lakshmipriya Nair Apr 1, 2020 Express Pharma series on the key pillars of a strategic framework to tackle zoonotic diseases
Reducing India’s Import Dependence on APIs: A possible way out EP News Bureau Mar 31, 2020 Reji K Joseph, Associate Professor at Institute for Studies in Industrial Development, New Delhi writes about how different bodies…
Book Launch Alert: ‘Innovation And Financial Performance In Indian Pharmaceutical… EP News Bureau Mar 31, 2020 The book, authored by Mithun Nandy, provides information and insight on the important areas where different research and…
Finding the silver lining about coronavirus pandemic Usha Sharma Mar 17, 2020 As India Pharma Inc reels under the far-reaching impact of the coronavirus epidemic, industry experts suggest policy reforms to…
PPL Conclave 2020 EP News Bureau Mar 3, 2020 Pharma Packaging and Labelling (PPL) Conclave, in its third edition, witnesses a confluence of pharma leaders and innovators…
ANDA approvals in 2019: Trends for the generics industry EP News Bureau Jan 16, 2020 Meenu Grover Sharma, Scholar Delhi Pharmaceutical Sciences & Research University, Principal Consultant, BusinessAssociar…
Will Budget 2020 be a salve or a sting for India Pharma Inc? Viveka Roychowdhury Jan 14, 2020 Will the sector get their shocks post-budget, via a revamped UCPMP, further pricing woes, etc?
Unlocking Potential EP News Bureau Dec 31, 2019 Experts outline plans of action for capability expansion, reforms and market leadership to step up India Pharma Inc's growth…